What podcasts say about Ozempic
Every statement, with the speaker, the exact quote and the moment it was said.
What experts have said about Ozempic
6 statements · 5 positive · 1 negative
Stopping Ozempic and GLP medications causes obesity, weight, and disease to return.
“as soon as you stop taking it, every study shows that obesity returns, weight gain, disease gain”
Open the episode · Get Healthy, with Gary Brecka, Andrew Huberman, and Sean O'MaraListen at 4:18:55
Semaglutide patent expirations enable Sandoz to sell cheaper generic versions.
“that's paving the way for generic drug companies like Sandoz to sell cheaper versions of this key ingredient”
Open the episode · Novartis Slumps, Sandoz Gains, Computacenter UpListen at 3:16
Ozempic reduced Hari’s intake and produced 42 pounds of first-year weight loss.
“It's why I went from eating 3,200 calories a day to about 1,800. It's why I lost 42 pounds in the first year.”
Open the episode · Best of Big Technology: How Ozempic Changes Our Bodies, Minds, and Economy — With Johann HariListen at 17:01
Novo Nordisk's 7.2-milligram semaglutide matched tirzepatide's weight-loss efficacy in a trial.
“We have done a trial called Step Up with semaglutide at 7.2 milligram that shows actually weight loss efficacy on par with trisepatide.”
Open the episode · Mad Money w/ Jim Cramer 2/4/26Listen at 13:57
High-dose semaglutide produces weight loss comparable to tirzepatide
“Step Up with semaglutide at 7.2 milligram that shows actually weight loss efficacy on par with trisepatide.”
Open the episode · Mad Money w/ Jim Cramer 2/4/26Listen at 13:58
Semaglutide provides cardiovascular, liver, and kidney protection.
“semaglutide gives you cardio protection, liver protection, kidney protection”
Open the episode · Mad Money w/ Jim Cramer 2/4/26Listen at 14:27
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.